Moderna Inc risk profile
60 Stretched several inputs deteriorating together
Measured 21 October 2026 from MRNA's filed statements. Recomputed nightly.
60 (Stretched), driven by Cash conversion at 100, over 8 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 43 | Elevated | Volatile | One-year price volatility — 193.7% |
| Operating pressure | 75 | Stretched | Easing | Costs outgrowing revenue — +9.8 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.10x |
| Leverage and coverage | 38 | Normal | Stable | Interest cover — -286.30x |
| Competitive position | 80 | Acute | Stable | Operating-margin gap against peers — -170.0 percentage points |
| Concentration | 62 | Stretched | Stable | Supplier concentration — 10,000 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.